Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Dec 19, 2023

BUY
$18.66 - $38.58 $1.12 Million - $2.31 Million
60,000 New
60,000 $2.31 Million
Q2 2023

Aug 15, 2023

BUY
$18.66 - $38.58 $1.12 Million - $2.31 Million
60,000 New
60,000 $2.31 Million
Q4 2020

Feb 12, 2021

SELL
$11.9 - $20.91 $216,687 - $380,750
-18,209 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$11.4 - $15.5 $207,582 - $282,239
18,209 New
18,209 $44,000

Others Institutions Holding KDNY

About CHINOOK THERAPEUTICS, INC.


  • Ticker KDNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,896,300
  • Description
  • Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...
More about KDNY
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.